ERBB2 and ovarian cancer: In invasion assays the findings are consistent with previous results as well, e.g., Zhang et al. developed HER-2-nanobody (NB)-conjugated human serum albumin (HSA) containing catalase (CAT) and chlorin (Ce6) for ovarian cancer treatment.